Literature DB >> 11948762

Deep brain stimulation for Parkinson's disease: patient selection and evaluation.

Anthony E Lang1, Hakan Widner.   

Abstract

Critical to the successful application of deep brain stimulation for the treatment Parkinson's disease is the proper selection of patients who will reliably benefit from this procedure and the successful evaluation of the responses obtained. This review will discuss the various factors influencing patient selection and summarize the recommended approach to patient assessment by using the Core Assessment Program for Surgical Interventions and Transplantation in Parkinson's Disease (CAPSIT-PD). Copyright 2002 Movement Disorder Society

Entities:  

Mesh：

Year:  2002        PMID： 11948762     DOI： 10.1002/mds.10149

Source DB:  PubMed          Journal:  Mov Disord        ISSN： 0885-3185            Impact factor:   10.338


  30 in total

1.  Deep brain stimulation in late stage Parkinson's disease: a retrospective cost analysis in Germany.

Authors:  Wassilios Meissner; Doreen Schreiter; Jens Volkmann; Thomas Trottenberg; Gerd-Helge Schneider; Volker Sturm; Guenther Deuschl; Andreas Kupsch
Journal:  J Neurol       Date:  2005-02       Impact factor: 4.849

2.  A 5-year prospective assessment of advanced Parkinson disease patients treated with subcutaneous apomorphine infusion or deep brain stimulation.

Authors:  Angelo Antonini; Ioannis U Isaias; Giorgia Rodolfi; Andrea Landi; Francesca Natuzzi; Chiara Siri; Gianni Pezzoli
Journal:  J Neurol       Date:  2010-10-23       Impact factor: 4.849

3.  Clinical and economic results of bilateral subthalamic nucleus stimulation in Parkinson's disease.

Authors:  V Fraix; J-L Houeto; C Lagrange; C Le Pen; P Krystkowiak; D Guehl; C Ardouin; M-L Welter; F Maurel; L Defebvre; A Rougier; A-L Benabid; V Mesnage; M Ligier; S Blond; P Burbaud; B Bioulac; A Destée; P Cornu; P Pollak
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-04       Impact factor: 10.154

Review 4.  Surgical treatment of Parkinson disease: past, present, and future.

Authors:  Andrew P Duker; Alberto J Espay
Journal:  Neurol Clin       Date:  2013-04-04       Impact factor: 3.806

5.  Intraoperative acceleration measurements to quantify improvement in tremor during deep brain stimulation surgery.

Authors:  Ashesh Shah; Jérôme Coste; Jean-Jacques Lemaire; Ethan Taub; W M Michael Schüpbach; Claudio Pollo; Erik Schkommodau; Raphael Guzman; Simone Hemm-Ode
Journal:  Med Biol Eng Comput       Date:  2016-09-08       Impact factor: 2.602

6.  Deep brain stimulation in early Parkinson's disease: enrollment experience from a pilot trial.

Authors:  P D Charles; R M Dolhun; C E Gill; T L Davis; M J Bliton; M G Tramontana; R M Salomon; L Wang; P Hedera; F T Phibbs; J S Neimat; P E Konrad
Journal:  Parkinsonism Relat Disord       Date:  2011-11-21       Impact factor: 4.891

7.  Customized, miniature rapid-prototype stereotactic frames for use in deep brain stimulator surgery: initial clinical methodology and experience from 263 patients from 2002 to 2008.

Authors:  Peter E Konrad; Joseph S Neimat; Hong Yu; Chris C Kao; Michael S Remple; Pierre-François D'Haese; Benoit M Dawant
Journal:  Stereotact Funct Neurosurg       Date:  2010-12-15       Impact factor: 1.875

8.  Functional improvement after subthalamic stimulation in Parkinson's disease: a non-equivalent controlled study with 12-24 month follow up.

Authors:  M Capecci; R A Ricciuti; D Burini; V G Bombace; L Provinciali; M Iacoangeli; M Scerrati; M G Ceravolo
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-06       Impact factor: 10.154

Review 9.  Deep brain stimulation for treatment-resistant depression: a psychiatric perspective.

Authors:  Peter Giacobbe; Sidney H Kennedy
Journal:  Curr Psychiatry Rep       Date:  2006-12       Impact factor: 5.285

10.  Association of MRI Measurements with Cognitive Outcomes After STN-DBS in Parkinson's Disease.

Authors:  Laura J Weinkle; Brian Hoyt; John A Thompson; Stefan Sillau; Jody Tanabe; Justin Honce; Olga Klepitskaya
Journal:  Mov Disord Clin Pract       Date:  2018-07-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.